Receptor‐mediated autocrine growth‐stimulatory effect of 5‐hydroxytryptamine on cultured human pancreatic carcinoid cells

Medicine and Dentistry

• Cell Growth 100%
• Cyclic AMP 100%
• Receptor Antagonist 100%
• Carcinoid 100%
• Mitogenesis 100%
• Phosphatidylinositol 66%
• Enzymatic Hydrolysis 66%
• Growth Factor 33%
• Receptor 33%
• Crypt Cell 33%
• Protein Kinases 33%
• Guanosine Phosphate 33%
• Vascular Smooth Muscle Cell 33%
• Guanine Nucleotide Binding Protein 33%
• Mitogenic Agent 33%
• Cyclic AMP Dependent Protein Kinase 33%
• Adenosine Phosphate 33%
• Carcinoid Cell Line 33%
• Growth Regulation 33%
• Mesangial Cell 33%
• Mesulergine 33%
• Pertussis Toxin 33%
• Fibroblast 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cyclic AMP 100%
• Receptor Antagonist 100%
• Carcinoid 100%
• Phosphatidylinositol 66%
• Growth Factor 33%
• Receptor 33%
• Guanosine Phosphate 33%
• Guanine Nucleotide Binding Protein 33%
• Adenosine Phosphate 33%
• Protein Kinases 33%
• Mitogenic Agent 33%
• Cyclic AMP Dependent Protein Kinase 33%
• Pertussis Toxin 33%
• Mesulergine 33%

Keyphrases

• Carcinoid 100%
• BON Cells 100%
• Receptor Antagonist 50%
• Cyclic Adenosine Monophosphate (cAMP) 50%
• Cell Growth 33%
• Protein Kinase 33%
• Hydrolysis 33%
• Phosphatidylinositol 33%
• Mitogen 16%
• Autocrine Growth Factors 16%
• Fibroblasts 16%
• Crypt Cells 16%
• Vascular Smooth muscle Cells 16%
• Cell Growth Regulation 16%
• 2 Receptor 16%
• Carcinoid Tumor 16%
• 5-HT1A 16%
• Pertussis Toxin 16%
• GTP-binding Proteins 16%
• Renal Mesangial Cells 16%